Pharmacometrics Archives

Video

Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling

Today’s drug candidates are more complex than ever. But with development decisions on the line,…

CertaraFebruary 12, 2025

Publication

Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies

This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2…

CertaraFebruary 6, 2025

Publication

Understanding Variability in CAR-T Cell Therapy Kinetics

Axicabtagene ciloleucel (axi-cel), a CAR-T cell therapy for relapsed and refractory non-Hodgkin’s lymphoma (NHL), demonstrates…

CertaraJanuary 23, 2025

Publication

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…

CertaraJanuary 8, 2025

Publication

Advancing pharmacometrics in Africa – Transition from capacity development toward job creation

This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…

CertaraDecember 9, 2024

Publication

Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women

The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…

CertaraNovember 18, 2024

Case Study

Enhancing Pharmacokinetics Workflows at Charles River

PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…

CertaraNovember 13, 2024

Blog

Why Clinical Pharmacology & Pharmacometrics Should Collaborate

A symbiosis between a modeler and a trialist is often required to develop a model-informed…

CertaraNovember 8, 2024

On-Demand Webinar

On-ramps to popPK: Building Better Models with GUI, Code, or Both

A critical component of popPK studies is popPK modeling, where mathematical models are developed to…

CertaraOctober 18, 2024

Case Study

Medicines that matter: Biohaven’s Nurtec™ drug development journey

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved…

CertaraAugust 15, 2024

Pharmacometrics

Certara’s Phoenix Platform – The world’s most trusted platform for PK/PD analysis and modeling

Population Pharmacokinetic and Pharmacodynamic Analysis of Navtemadlin in Patients with Relapsed and Refractory (R/R) Myelofibrosis (MF) and Other Myeloid or Solid Tumor Malignancies

Understanding Variability in CAR-T Cell Therapy Kinetics

INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer’s disease

Advancing pharmacometrics in Africa – Transition from capacity development toward job creation

Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women

Enhancing Pharmacokinetics Workflows at Charles River

Why Clinical Pharmacology & Pharmacometrics Should Collaborate

On-ramps to popPK: Building Better Models with GUI, Code, or Both

Medicines that matter: Biohaven’s Nurtec™ drug development journey

Newsletter sign up

Quick links

Solutions

Contact